Skip to main content
SpringerLink
Log in

Schwerpunkt APL

Die akute Promyelozytenleukämie - ein hämatologischer Notfall

  • Schwerpunkt
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

© Irina Zhurba, UKE

2

© Irina Zhurba, UKE

3

Literatur

  1. Cingam SR, Koshy NV. Acute Promyelocytic Leukemia. Treasure Island (FL): StatPearls; 2022 www.ncbi.nlm.nih.gov/books/NBK459352 abgerufen am 17. November 2022

  2. Lengfelder E et al. Akute Promyelozyten Leukämie (APL) 2020 www.onkopedia.com/de/onkopedia/guidelines/akute-promyelozyten-leukaemie-apl abgerufen am 17. November 2022

  3. Adams J, Nassiri M. Acute Promyelocytic Leukemia: A Review and Discussion of Variant Translocations. Arch Pathol Lab Med. 2015;139(10):1308-13

  4. Dinmohamed AG, Visser O. Incidence of acute promyelocytic leukemia across Europe: results of RARECAREnet-a population-based study. Stem Cell Investig. 2019;6:37

  5. Hasan SK et al. Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci. Genes Chromosomes Cancer. 2010;49(8):726-32

  6. Braun T et al. Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group. Cancer. 2015;121(14):2393-9

  7. Khoury JD et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36(7):1703-19

  8. Arber DA et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-405

  9. Dohner H et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345-77

  10. Sanz MA et al. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood. 2019;133(15):1630-43

  11. Ablain J, de The H. Revisiting the differentiation paradigm in acute promyelocytic leukemia. Blood. 2011;117(22):5795-802

  12. Madan V et al. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia. 2016;30(12):2430

  13. Sanz MA et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood. 2000;96(4):1247-53

  14. Brissot E et al. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2021;56(3):532-5

  15. Lengfelder E et al. High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. Leukemia. 2009;23(12):2248-58

  16. Abaza Y et al. Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. Blood. 2017;129(10):1275-83

  17. Iland HJ et al. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial. Lancet Haematol. 2015;2(9):e357-66

  18. Stahl M, Tallman MS. Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all. Leuk Lymphoma. 2019;60(13):3107-15

  19. Lehmann S et al. Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013. Leukemia. 2017;31(6):1457-9

  20. Altman JK et al. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death. Leuk Res. 2013;37(9):1004-9

  21. Park JH et al. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood. 2011;118(5):1248-54

  22. McClellan JS et al. Treatment advances have not improved the early death rate in acute promyelocytic leukemia. Haematologica. 2012;97(1):133-6

  23. Hambley BC et al. Coagulopathy in Acute Promyelocytic Leukemia: Can We Go Beyond Supportive Care? Front Med (Lausanne). 2021;8:722614

  24. Avvisati G et al. Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia. Br J Haematol. 1988;70(1):43-8

  25. Menell JS et al. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med. 1999;340(13):994-1004

  26. Kwaan HC et al. Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin. J Thromb Haemost. 2004;2(2):306-12

  27. Sakata Y et al. The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia. Blood. 1991;77(9):1949-57

  28. Egbring R et al. Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood. 1977;49(2):219-31

  29. Oudijk EJ et al. Elastase mediated fibrinolysis in acute promyelocytic leukemia. Thromb Haemost. 2000;83(6):906-8

  30. Yang R et al. Neutrophil elastase enhances the proliferation and decreases apoptosis of leukemia cells via activation of PI3K/Akt signaling. Mol Med Rep. 2016;13(5):4175-82

  31. Yu L et al. Neutrophil elastase-mediated proteolysis of the tumor suppressor p200 CUX1 promotes cell proliferation and inhibits cell differentiation in APL. Life Sci. 2020;242:117229

  32. Ma G et al. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia. Ann Hematol. 2013;92(5):645-52

  33. Langer F et al. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation. Ann Hematol. 2008;87(6):451-7

  34. Falanga A et al. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood. 1998;92(1):143-51

  35. Dubois C et al. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood. 1994;83(11):3264-70

  36. Schorer AE et al. Interleukin 1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanism. Thromb Haemost. 1986;56(3):256-9

  37. Schleef RR et al. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem. 1988;263(12):5797-803

  38. Lentz SR et al. Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms. Blood. 1991;77(3):542-50

  39. Nan B et al. Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Thromb Res. 2005;115(5):417-26

  40. Tan et al. A PML/RARα direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia Blood. 2021;137(11):1503-16

Download references

Author information

Authors and Affiliations

  1. II. Medizinische Klinik, Abteilung für Onkologie, Hämatologie und Knochenmarktransplantation mit Division Pneumologie, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Deutschland

    Franziska Modemann,  Susanne Ghandili & Irina Zhurba

  2. Zentrum für Onkologie, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Deutschland

    Florian Langer

  3. Univ.-Klinikum Hamburg-Eppendorf, Klinik f. Onkol., Hämatol. u. Stammzellentransplantation, Martinistr. 52, 22046, Hamburg, Deutschland

    Carsten Bokemeyer

  4. II. Medizinische Klinik und Poliklinik für Onkologie, Hämatologie und Knochenmarktransplantation mit der Sektion Pneumologie, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Deutschland

    Walter Fiedler

Authors
  1. Franziska Modemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susanne Ghandili
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Irina Zhurba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Florian Langer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carsten Bokemeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Walter Fiedler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Modemann, F., Ghandili, S., Zhurba, I. et al. Die akute Promyelozytenleukämie - ein hämatologischer Notfall. InFo Hämatol Onkol 25, 10–15 (2022). https://doi.org/10.1007/s15004-022-9772-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-022-9772-1

Search

Navigation